Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dihydrocapsiate (Standard)
Cat. No.:
OB0425LY-367
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Dihydrocapsiate (Standard) is an orally active TRPV1 agonist that belongs capsinoid family.
Synonyms:
Dihydrocapsiate; 205687-03-2; 4-Hydroxy-3-methoxybenzyl 8-methylnonanoate; Nonanoic acid, 8-methyl-, (4-hydroxy-3-methoxyphenyl)methyl ester; Vanillyl 8-methylnonanoate
CAS No.:
205687-03-2
Compound CID:
9873754
Formula:
C18H28O4
Formula Weight:
308.41
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Dihydrocapsiate (Standard) is evaluated for its potential effects on thermogenesis and fat oxidation, contributing to weight management strategies.
